Literature DB >> 8930030

Distress reduction during the structured clinical interview for DSM-III-R.

P A Scarvalone1, M Cloitre, L A Spielman, L Jacobsberg, B Fishman, S W Perry.   

Abstract

In an attempt to assess the influence of standardized diagnostic interviews on psychological distress in research volunteers, the Visual Analogue Scale (VAS) was used to measure anxiety and depression during the Structured Clinical Interview for DSM-III-R, Non-patient version (SCID). Subjects were 50 adults with concerns related to the human immunodeficiency virus who were seeking testing and treatment in research trials. Repeated measures analysis of variance showed significant decreases in distress by the end of the interview: 72% of subjects reported diminished anxiety, and 54% reported diminished depression. Thus, the SCID appeared to provide a positive interview experience, a finding that may serve to reassure subjects, their families, and review boards regarding participation in studies that employ structured interviews.

Entities:  

Mesh:

Year:  1996        PMID: 8930030     DOI: 10.1016/0165-1781(95)02802-1

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  3 in total

1.  Burden and benefit of psychosocial research at the end of life.

Authors:  Hayley Pessin; Michele Galietta; Christian J Nelson; Robert Brescia; Barry Rosenfeld; William Breitbart
Journal:  J Palliat Med       Date:  2008-05       Impact factor: 2.947

2.  Acute effects of trauma-focused research procedures on participant safety and distress.

Authors:  Vanessa M Brown; Jennifer L Strauss; Kevin S LaBar; Andrea L Gold; Gregory McCarthy; Rajendra A Morey
Journal:  Psychiatry Res       Date:  2013-11-08       Impact factor: 3.222

3.  Contribution of substance abuse and HIV infection to psychiatric distress in an inner-city African-American population.

Authors:  C U Nnadi; W Better; K Tate; R I Herning; Jean Lud Cadet
Journal:  J Natl Med Assoc       Date:  2002-05       Impact factor: 1.798

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.